Epithelial‐to‐mesenchymal transition (EMT) to sarcoma in recurrent lung adenosquamous carcinoma following adjuvant chemotherapy
Adjuvant chemotherapy has long been indicated to extend survival in completely resected stage IB to IIIA non-small cell lung cancer (NSCLC). However, there is accumulating evidence that chemotherapy or chemoradiotherapy can induce epithelial-to-mesenchymal transition (EMT) in disseminated or circula...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Published: |
Wiley Open Access
2019
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/23749/ https://doi.org/10.1111/1759-7714.13156 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
my.um.eprints.23749 |
---|---|
record_format |
eprints |
spelling |
my.um.eprints.237492021-03-23T02:26:07Z http://eprints.um.edu.my/23749/ Epithelial‐to‐mesenchymal transition (EMT) to sarcoma in recurrent lung adenosquamous carcinoma following adjuvant chemotherapy Poh, Mau Ern Liam, Chong Kin Mun, Kein Seong Chai, Chee Shee Wong, Chee Kuan Tan, Jiunn Liang Loh, Thian Chee Chin, Ka Kiat R Medicine Adjuvant chemotherapy has long been indicated to extend survival in completely resected stage IB to IIIA non-small cell lung cancer (NSCLC). However, there is accumulating evidence that chemotherapy or chemoradiotherapy can induce epithelial-to-mesenchymal transition (EMT) in disseminated or circulating NSCLC cells. Here, we describe the first case of EMT as the cause of recurrence and metastasis in a patient with resected stage IIB lung adenosquamous carcinoma after adjuvant chemotherapy. We review the literature and explore the possible mechanisms by which EMT occurs in disseminated tumor cells (DTC) or circulating tumor cells (CTC) in response to adjuvant chemotherapy (cisplatin) as a stressor. We also explore the possible therapeutic strategies to reverse EMT in patients with recurrence. In summary, although adjuvant cisplatin-based chemotherapy in resected NSCLC does extend survival, it may lead to the adverse phenomenon of EMT in disseminated tumor cells (DTC) or circulating tumor cells (CTC) causing recurrence and metastasis. © 2019 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd Wiley Open Access 2019 Article PeerReviewed Poh, Mau Ern and Liam, Chong Kin and Mun, Kein Seong and Chai, Chee Shee and Wong, Chee Kuan and Tan, Jiunn Liang and Loh, Thian Chee and Chin, Ka Kiat (2019) Epithelial‐to‐mesenchymal transition (EMT) to sarcoma in recurrent lung adenosquamous carcinoma following adjuvant chemotherapy. Thoracic Cancer, 10 (9). pp. 1841-1845. ISSN 1759-7706 https://doi.org/10.1111/1759-7714.13156 doi:10.1111/1759-7714.13156 |
institution |
Universiti Malaya |
building |
UM Library |
collection |
Institutional Repository |
continent |
Asia |
country |
Malaysia |
content_provider |
Universiti Malaya |
content_source |
UM Research Repository |
url_provider |
http://eprints.um.edu.my/ |
topic |
R Medicine |
spellingShingle |
R Medicine Poh, Mau Ern Liam, Chong Kin Mun, Kein Seong Chai, Chee Shee Wong, Chee Kuan Tan, Jiunn Liang Loh, Thian Chee Chin, Ka Kiat Epithelial‐to‐mesenchymal transition (EMT) to sarcoma in recurrent lung adenosquamous carcinoma following adjuvant chemotherapy |
description |
Adjuvant chemotherapy has long been indicated to extend survival in completely resected stage IB to IIIA non-small cell lung cancer (NSCLC). However, there is accumulating evidence that chemotherapy or chemoradiotherapy can induce epithelial-to-mesenchymal transition (EMT) in disseminated or circulating NSCLC cells. Here, we describe the first case of EMT as the cause of recurrence and metastasis in a patient with resected stage IIB lung adenosquamous carcinoma after adjuvant chemotherapy. We review the literature and explore the possible mechanisms by which EMT occurs in disseminated tumor cells (DTC) or circulating tumor cells (CTC) in response to adjuvant chemotherapy (cisplatin) as a stressor. We also explore the possible therapeutic strategies to reverse EMT in patients with recurrence. In summary, although adjuvant cisplatin-based chemotherapy in resected NSCLC does extend survival, it may lead to the adverse phenomenon of EMT in disseminated tumor cells (DTC) or circulating tumor cells (CTC) causing recurrence and metastasis. © 2019 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd |
format |
Article |
author |
Poh, Mau Ern Liam, Chong Kin Mun, Kein Seong Chai, Chee Shee Wong, Chee Kuan Tan, Jiunn Liang Loh, Thian Chee Chin, Ka Kiat |
author_facet |
Poh, Mau Ern Liam, Chong Kin Mun, Kein Seong Chai, Chee Shee Wong, Chee Kuan Tan, Jiunn Liang Loh, Thian Chee Chin, Ka Kiat |
author_sort |
Poh, Mau Ern |
title |
Epithelial‐to‐mesenchymal transition (EMT) to sarcoma in recurrent lung adenosquamous carcinoma following adjuvant chemotherapy |
title_short |
Epithelial‐to‐mesenchymal transition (EMT) to sarcoma in recurrent lung adenosquamous carcinoma following adjuvant chemotherapy |
title_full |
Epithelial‐to‐mesenchymal transition (EMT) to sarcoma in recurrent lung adenosquamous carcinoma following adjuvant chemotherapy |
title_fullStr |
Epithelial‐to‐mesenchymal transition (EMT) to sarcoma in recurrent lung adenosquamous carcinoma following adjuvant chemotherapy |
title_full_unstemmed |
Epithelial‐to‐mesenchymal transition (EMT) to sarcoma in recurrent lung adenosquamous carcinoma following adjuvant chemotherapy |
title_sort |
epithelial‐to‐mesenchymal transition (emt) to sarcoma in recurrent lung adenosquamous carcinoma following adjuvant chemotherapy |
publisher |
Wiley Open Access |
publishDate |
2019 |
url |
http://eprints.um.edu.my/23749/ https://doi.org/10.1111/1759-7714.13156 |
_version_ |
1695531081626812416 |
score |
13.164666 |